Hosted on MSN

PLSE wins FDA IDE approval to launch nPulse AF ablation study trial

Pulse Biosciences PLSE recently announced that the FDA has granted Investigational Device Exemption (“IDE”) approval to initiate its nPulse Cardiac Catheter Ablation System study for the treatment of ...
Seeking Alpha

Pulse Biosciences Announces FDA IDE Approval to Initiate its nPulse Cardiac Catheter Ablation System Study for the Treatment of Atrial Fibrillation

HAYWARD, Calif.--(BUSINESS WIRE)-- Pulse Biosciences, Inc. (PLSE), a company leveraging its novel nPulse™ technology using its proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) ...
Healio

All-in-one ablation catheter shows good safety, promise in treating paroxysmal AF

Please provide your email address to receive an email when new articles are posted on . An all-in-one ablation system showed durable pulmonary vein isolation at 1 year. Three-quarters of patients ...
Medscape

Spherical Ablation Catheter Provides Unprecedented Control of Atrial Fibrillation at 1 Year

SAN DIEGO — Building on the success of a growing number of devices employing pulsed field ablation to control treatment-resistant paroxysmal atrial fibrillation (AF), a new spherical device produced ...